BACKGROUND: Catatonia was first described by Kahlbaum as a psychomotor dise
ase with motor, behavioral, and affective symptoms. Tn keeping with this co
ncept, we developed a rating scale for catatonia (Northoff Catatonia Scale
[NCS]) with three different categories of symptoms (i.e., motor, behavioral
, affective). Furthermore, the question of the relationship among catatonic
symptoms, extrapyramidal motor symptoms, and neuroleptics was addressed in
the present study.
METHOD: 34 acute catatonic patients and 68 age-, sex-, diagnosis-, and medi
cation-matched psychiatric control subjects were investigated on days 0, 1,
3, 7, and 21 with the NCS, with other already validated catatonia rating s
cales by Rosebush, Bush (BFCRS), and Rogers (MRS), as well as with scales f
or hypokinetic (SEPS) and dyskinetic (AIMS) extrapyramidal motor features.
Validity and reliability of the new scale, factor analysis, correlational a
nalysis, and differences between catatonic patients and psychiatric control
subjects were statistically calculated.
RESULTS: NCS showed high validity (i.e., significant positive correlations
[p < 0.0001] with the other scales, significant differences between cataton
ic and control subjects), high intra- and interrater reliabilities (r = 0.8
0-0.96), and high affective subscores. Factor analysis revealed four factor
s best characterized as affective, hypoactive, hyperactive, and behavioral.
Catatonic scores in NCS correlated significantly with AIMS on day 0 and SE
PS on days 7 and 21. There were no significant differences in catatonic (i.
e., NCS, MRS, BFCRS) and extra-pyramidal (i.e., AIMS, SEPS) scores between
neuroleptically treated and untreated catatonic subjects.
CONCLUSIONS: The following conclusions were drawn: (1) the NCS has to be co
nsidered as a valid and reliable rating instrument for catatonia; (2) catat
onia can be characterized by psychomotor symptoms encompassing motor, affec
tive, and behavioral alterations; and (3) extrapyramidal hyperkinesias like
dyskinesias are apparently closely related to catatonic symptoms which, in
general, seem to be relatively independent of previous neuroleptic medicat
ion.